ribavirin has been researched along with Liver Dysfunction in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (6.52) | 18.2507 |
| 2000's | 28 (60.87) | 29.6817 |
| 2010's | 13 (28.26) | 24.3611 |
| 2020's | 2 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HY; Zhao, JM | 1 |
| Dourakis, SP; Fragkou, PC; Karofylakis, E; Kavvatha, D; Liatsos, GD; Marantos, T; Pirounaki, M; Sambatakou, H; Sympardi, S; Thomas, K; Tsiodras, S | 1 |
| Apostu, D; Campian, RS; Ciobanu, L; Ilea, A; Lucaciu, O; Mester, A | 1 |
| Barbato, A; Cimino, E; Coppola, A; Di Minno, MN; Granata, F; Liccardo, S; Rossi, D; Ruosi, C | 1 |
| Anthony, DD; Blanton, RE; Judge, CJ; Meng, Q; Phat, S; Rani, MR; Rodriguez, B; Sugalski, JM | 1 |
| Barin, B; Barnes, D; Curry, M; Dove, L; Johl, J; Millis, M; Peters, M; Poordad, F; Reddy, KR; Regenstein, F; Roland, M; Schiano, T; Schiff, E; Shaikh, O; Shetty, K; Stock, P; Terrault, N | 1 |
| Asselah, T; Boyer, N; Duval, X; Guedj, J; Kutala, BK; Marcellin, P; Martinot-Peignoux, M; Mouri, F; Valla, D | 1 |
| Akhtar, M; Gititu, E; Jalluri, C; Ramirez, J; Wilkins, T | 1 |
| Clark, S; Cooke, GS; Gellissen, R; Irving, W; Main, J; Padam, P; Thomson, E | 1 |
| Bahirwani, R; Berg, C; Brown, RS; Castells, L; Chacko, KR; Durand, CM; ElSharkawy, AM; Emond, B; Ferenci, P; Fontana, RJ; Herzer, K; Ionescu-Ittu, R; Jafri, SM; Joshi, S; Knop, V; Lionetti, R; Loiacono, L; Londoño, MC; Montalbano, M; Moreno-Zamora, A; Mubarak, A; Pellicelli, AM; Prieto, M; Reddy, KR; Stadler, B; Stauber, RE; Stenmark, S; Torti, C; Vekeman, F; Weiland, O | 1 |
| Ingiliz, P; Jimenez-Exposito, MJ; Peck-Radosavljevic, M; Petersen, J; Rockstroh, JK; Van der Valk, M; Welzel, TM; Zeuzem, S; Zhao, Y | 1 |
| Pár, A; Pár, G | 1 |
| Bailey, KW; Furuta, Y; Gowen, BB; Hall, JO; Jung, KH; Morrey, JD; Smee, DF; Stevens, JR; Wong, MH | 1 |
| Buck, M; Feldstein, A; Kleiner, D; Kravetz, D | 1 |
| Abradelo, M; Colina, F; Fernández, I; Gimeno, A; Jiménez, C; Lumbreras, C; Meneu, JC; Moreno, E; Solís-Herruzo, JA; Ulloa, E | 1 |
| Aghemo, A; Colombo, M; Coppola, A; Mancuso, ME; Mannucci, PM; Puoti, M; Rumi, MG; Santagostino, E | 1 |
| Badley, AD; Cummins, NW; Klein, MB; Rider, DN; Rizza, SA; Saeed, S | 1 |
| Bukh, J | 1 |
| Naggie, S; Sulkowski, MS | 1 |
| Brjalin, V; Jõeste, E; Lapidus, N; Prikk, K; Salupere, R; Tefanova, V | 1 |
| Allan, JE; de Boer, WB; Jeffrey, GP; MacQuillan, GC; McCaul, KA; Platten, MA; Reed, WD | 1 |
| Allan, JE; Jeffrey, GP; MacQuillan, GC; Mamotte, C; Reed, WD | 1 |
| Bacon, BR | 1 |
| Chen, XG; Cui, HJ; Duan, J; Gong, YW; Hao, YX; Hua, CJ; Li, AG; Li, P; Tong, XL; Zhang, B; Zhang, ZY; Zhen, M | 1 |
| Guzman, H; Sbrana, E; Tesh, RB; Travassos da Rosa, AP; Xiao, SY; Ye, M | 1 |
| González-Peralta, RP | 1 |
| Ascher, NA; Bollinger, K; Khalili, M; Roberts, JP; Shergill, AK; Straley, S; Terrault, NA | 1 |
| Cengiz, C; Dieterich, DT; Park, JS; Saraf, N | 1 |
| Maier, KP | 1 |
| Dieterich, DT; Park, JS; Saraf, N | 1 |
| Beckebaum, S; Broelsch, CE; Cicinnati, VR; Gerken, G | 1 |
| Brok, J; Gluud, C; Gong, Y; Koretz, RL | 1 |
| Kallman, J; Kincaid, J; Younossi, Z | 1 |
| Bortolotti, F; Guido, M | 1 |
| Fiel, MI; Saraf, N; Schiano, TD; Shukla, D; Xu, R | 1 |
| Basgoz, N; Bica, I; Birch, C; Davis, B; Gandhi, RT; Graeme-Cook, F; McGovern, BH; Quirk, JR; Stone, D; Zachary, K; Zaman, MT | 1 |
| Adla, M; Ahmad, J; Downey, KK | 1 |
| Juszczyk, J | 1 |
| Brinton, MA; Gavin, EI; Lo, WK; Morahan, PS; Pinto, AJ | 1 |
| Clarysse, C; Suwandhi, W; Verslype, C; Yap, SH | 1 |
| Clement, RP; Glue, P; Gupta, S; Salfi, M; Schenker, S; Zambas, D | 1 |
| Mert, A; Ozaras, R; Ozbay, G; Senturk, H; Tabak, F; Tahan, V | 1 |
| Di Bisceglie, AM | 1 |
| Donahue, P; Hasan, I; Lebovics, E; Rehman, R; Rigas, B; Wittkowski, KM | 1 |
| Di Bisceglie, AM; McHutchison, J; Rice, CM | 1 |
| Koczorek, M | 1 |
17 review(s) available for ribavirin and Liver Dysfunction
| Article | Year |
|---|---|
Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP.
Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis C; Humans; Inflammation; Interferon-alpha; Lichen Planus, Oral; Liver Diseases; Male; Middle Aged; Prevalence; Ribavirin | 2018 |
Diagnosis and Management of Hepatitis C.
Topics: Antiviral Agents; Disease Progression; Genotype; Hepacivirus; Hepatitis Antibodies; Hepatitis C; Humans; Interferon-alpha; Liver Diseases; Mass Screening; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Severity of Illness Index; Viral Load; Viral Nonstructural Proteins | 2015 |
Animal models for the study of hepatitis C virus infection and related liver disease.
Topics: Animals; Antibodies, Neutralizing; Antiviral Agents; Carcinoma, Hepatocellular; Cercopithecidae; Disease Models, Animal; Disease Susceptibility; Hepatitis Antibodies; Hepatitis C; Humans; Immunity, Innate; Interferon-alpha; Liver Diseases; Liver Neoplasms; Mice; Mice, SCID; Pan troglodytes; Platyrrhini; Ribavirin; Virus Replication | 2012 |
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Deoxycytidine; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Diseases; Male; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Pyrrolidinones; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Substance Abuse, Intravenous; Tenofovir; Treatment Outcome | 2012 |
Managing hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Polyethylene Glycols; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; United States | 2004 |
HIV and liver diseases: recent clinical advances.
Topics: Anti-HIV Agents; Antiviral Agents; Hepatitis C; HIV Infections; Humans; Interferons; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Ribavirin | 2005 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Drug Therapy, Combination; Fatty Liver; Hemochromatosis; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Interferons; Lamivudine; Liver Cirrhosis, Biliary; Liver Diseases; Organophosphonates; Prednisolone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors | 2005 |
HBV plus HCV, HCV plus HIV, HBV plus HIV.
Topics: Algorithms; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Disease Progression; Drug Interactions; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load | 2006 |
[Recurrent disease after liver transplantation. A therapeutic dilemma or treatable?].
Topics: Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Cholestasis, Intrahepatic; Disease-Free Survival; Follow-Up Studies; Hepatitis B; Hepatitis C; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Incidence; Interferon-alpha; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Liver Transplantation; Middle Aged; Patient Compliance; Prognosis; Recurrence; Ribavirin; Risk Factors; Time Factors | 2006 |
Hepatology may have problems with putative surrogate outcome measures.
Topics: Antiviral Agents; Bilirubin; Biomarkers; Cholagogues and Choleretics; Gastroenterology; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis, Biliary; Liver Diseases; Outcome Assessment, Health Care; Reproducibility of Results; Ribavirin; Ursodeoxycholic Acid; Viral Load | 2007 |
The effects of HCV infection and management on health-related quality of life.
Topics: Antiviral Agents; Chronic Disease; Depression; Fatigue; Health Status; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin | 2007 |
Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Biopsy; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Liver Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
Hepatic sarcoidosis associated with pegylated interferon alfa therapy for chronic hepatitis C: case report and review of literature.
Topics: Adult; Antiviral Agents; Biopsy; Chemical and Drug Induced Liver Injury; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Diseases; Male; Peptidyl-Dipeptidase A; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis | 2008 |
[Advances in the research of viral hepatitis].
Topics: Hepatovirus; Humans; Interferons; Liver Diseases; Research; Ribavirin | 1994 |
Hepatitis C: seven years after the discovery of the causative agent.
Topics: Antiviral Agents; Genome, Viral; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Diseases; Ribavirin; RNA, Viral | 1997 |
Hepatic granulomas in chronic hepatitis C.
Topics: Biopsy, Needle; Drug Therapy, Combination; Female; Follow-Up Studies; Granuloma; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Diseases; Liver Function Tests; Middle Aged; Ribavirin; Risk Assessment; Treatment Outcome | 2001 |
New therapeutic strategies for hepatitis C.
Topics: Animals; Antiviral Agents; Cell Culture Techniques; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Humans; IMP Dehydrogenase; Interferons; Liver Diseases; Ribavirin; Virus Replication | 2002 |
2 trial(s) available for ribavirin and Liver Dysfunction
| Article | Year |
|---|---|
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.
Topics: Adult; Female; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferons; Liver Diseases; Male; Polyethylene Glycols; Ribavirin; Treatment Outcome | 2009 |
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Growth Substances; Hepatitis C; Humans; Immunocompromised Host; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Interferons; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Prednisone; Recombinant Proteins; Ribavirin; Tacrolimus; Time Factors | 2005 |
27 other study(ies) available for ribavirin and Liver Dysfunction
| Article | Year |
|---|---|
[Intrahepatic and extrahepatic clinical manifestations and treatment progress for hepatitis type E].
Topics: Antiviral Agents; Hepatitis E virus; Hepatitis, Chronic; Humans; Liver Diseases; Liver Failure; Ribavirin | 2023 |
Clinical characteristics and outcomes of measles outbreak in adults: A multicenter retrospective observational study of 93 hospitalized adults in Greece.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antiviral Agents; Female; Greece; Hospitalization; Humans; Liver Diseases; Male; Measles; Measles virus; Middle Aged; Pneumonia; Pregnancy; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome; Vaccination; Young Adult | 2020 |
Our experience about the particular surgical management of total hip replacement in two patients with severe haemophilic arthropathy: case report.
Topics: Antiviral Agents; Arthropathy, Neurogenic; Arthroplasty, Replacement, Hip; Drug Therapy, Combination; Hemophilia A; Hepatitis C; Hip; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Male; Middle Aged; Polyethylene Glycols; Radiography; Recombinant Proteins; Ribavirin; Severity of Illness Index | 2013 |
Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chronic H
Topics: Adult; Antiviral Agents; Black or African American; Female; Gene Expression Regulation; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Killer Cells, Natural; Liver Diseases; Lysosomal-Associated Membrane Protein 1; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2014 |
Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Liver Diseases; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prognosis; Prospective Studies; Recombinant Proteins; Ribavirin; Survival Rate; Transplant Recipients; Treatment Outcome; Young Adult | 2014 |
Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver disease.
Topics: Adult; Antiviral Agents; Female; Hepacivirus; Humans; Interferons; Liver Diseases; Male; Middle Aged; Prospective Studies; Ribavirin | 2015 |
Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease.
Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Delivery of Health Care; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Liver Diseases; Male; Middle Aged; Patient Acceptance of Health Care; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Viral Load | 2016 |
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
Topics: Aged; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Treatment Outcome; Valine | 2016 |
Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV-HCV coinfection and advanced liver disease.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Imidazoles; Liver Diseases; Liver Function Tests; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine; Viral Load | 2017 |
[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].
Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Delayed-Action Preparations; Europe; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Niacinamide; Oligopeptides; Patient Compliance; Phenylurea Compounds; Polyethylene Glycols; Proline; Pyridines; Recombinant Proteins; Ribavirin; Societies, Medical; Sorafenib | 2008 |
Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.
Topics: Absorption; Administration, Oral; Alanine Transaminase; Amides; Animals; Arenaviridae Infections; Aspartate Aminotransferases; Cricetinae; Disease Models, Animal; Disease Progression; Female; Hemorrhagic Fevers, Viral; Interferon Type I; Liver Diseases; Mesocricetus; Pichinde virus; Pyrazines; Ribavirin; Survival Analysis; Treatment Outcome; Viral Load | 2008 |
Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor.
Topics: Antiviral Agents; Apoptosis; Benzofurans; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Interferons; Liver; Liver Diseases; Male; Middle Aged; Polyethylene Glycols; Ribavirin; Sulfonamides | 2009 |
Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Interferons; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Ribavirin; Risk Factors; Treatment Outcome | 2009 |
Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals.
Topics: Adult; Antiviral Agents; Canada; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Male; Middle Aged; Polymorphism, Genetic; Receptors, Tumor Necrosis Factor, Member 25; Recombinant Proteins; Ribavirin; RNA, Viral | 2010 |
Sarcoidosis and chronic hepatitis C: a case report.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Biopsy; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Diseases; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis; Sarcoidosis, Pulmonary; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.
Topics: Adult; Antiviral Agents; Case-Control Studies; Cohort Studies; eIF-2 Kinase; GTP-Binding Proteins; Hepatitis C, Chronic; Humans; Immunohistochemistry; Interferon alpha-2; Interferon-alpha; Liver; Liver Diseases; Myxovirus Resistance Proteins; Proteins; Recombinant Proteins; Ribavirin | 2002 |
Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection.
Topics: 2',5'-Oligoadenylate Synthetase; Adult; Cytokines; Drug Therapy, Combination; eIF-2 Kinase; Female; GTP-Binding Proteins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukin-8; Liver; Liver Diseases; Male; Myxovirus Resistance Proteins; Proteins; Recombinant Proteins; Ribavirin; RNA, Messenger; Ubiquitins; Up-Regulation | 2003 |
Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Child; Female; Humans; Incidence; L-Lactate Dehydrogenase; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome | 2004 |
Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease.
Topics: Animals; Antiviral Agents; Cricetinae; Female; Liver Diseases; Mesocricetus; Models, Animal; Ribavirin; Treatment Outcome; Yellow Fever | 2004 |
Treatment of chronic hepatitis C in children.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2004 |
Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Female; Granuloma; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Sarcoidosis | 2008 |
Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.
Topics: Anti-HIV Agents; Antiviral Agents; Biopsy; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Female; Hepatitis C; HIV; HIV Infections; Humans; Interferons; Liver; Liver Cirrhosis; Liver Diseases; Male; Necrosis; Ribavirin; RNA, Viral; Transaminases; Viral Load | 2007 |
Characterization of murine Caraparu Bunyavirus liver infection and immunomodulator-mediated antiviral protection.
Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Bunyaviridae Infections; Female; Interferon-gamma; Liver; Liver Diseases; Mice; Mice, Inbred Strains; Microscopy, Electron; Orthobunyavirus; Recombinant Proteins; Ribavirin; Virus Replication | 1993 |
The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease.
Topics: Adult; Chronic Disease; Female; Humans; Liver Diseases; Male; Middle Aged; Ribavirin | 2000 |
SEN and sensibility: interactions between newly discovered and other hepatitis viruses?
Topics: Antiviral Agents; DNA Virus Infections; DNA Viruses; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Recombinant Proteins; Ribavirin; Treatment Outcome | 2001 |
Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C.
Topics: Alanine Transaminase; Antiviral Agents; DNA Primers; DNA Virus Infections; DNA Viruses; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Male; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Sequence Analysis, DNA; Treatment Outcome | 2001 |
[Chronic liver diseases. The nihilism has gone].
Topics: Amantadine; Antioxidants; Antiviral Agents; Chronic Disease; Dipeptides; Drug Therapy, Combination; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Diseases; Pentoxifylline; Phosphodiesterase Inhibitors; Prospective Studies; Protective Agents; Ribavirin; Silymarin | 2001 |